SE8304415L - NEW TETRAZINE DERIVATIVES - Google Patents

NEW TETRAZINE DERIVATIVES

Info

Publication number
SE8304415L
SE8304415L SE8304415A SE8304415A SE8304415L SE 8304415 L SE8304415 L SE 8304415L SE 8304415 A SE8304415 A SE 8304415A SE 8304415 A SE8304415 A SE 8304415A SE 8304415 L SE8304415 L SE 8304415L
Authority
SE
Sweden
Prior art keywords
group
optionally substituted
substituted phenyl
alkyl
hereinbefore defined
Prior art date
Application number
SE8304415A
Other languages
Swedish (sv)
Other versions
SE8304415D0 (en
SE455198B (en
Inventor
G U Baig
M F G Stevens
E Lunt
C G Newton
B L Pedgrift
C Smith
C G Straw
R J A Walsh
P J Warren
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838306904A external-priority patent/GB8306904D0/en
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of SE8304415D0 publication Critical patent/SE8304415D0/en
Publication of SE8304415L publication Critical patent/SE8304415L/en
Publication of SE455198B publication Critical patent/SE455198B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems

Abstract

NEW TETRAZINE DERIVATIVES Tetrazine derivatives of the general formula: <IMG> ¢wherein R1 represents a (C3-C8)cycloalkyl group, or a (C1-C4)alkyl, (C2-C6)alkenyl or (C2-C6)alkynyl group, each such alkyl, alkenyl or alkynyl group being unsubstituted or substituted by from 1 to 3 substituents selected from halogen atoms, (C1-C4)alkoxy, -alkylthio, -alkylsulphinyl and -alkylsulphonyl groups, and optionally substituted phenyl groups, A1 represents a nitrogen atom or a group -CR3= wherein R3 represents hydrogen or a substituent R4 wherein R4 represents a halogen atom, or a (C1-C6)-alkyl or -alkenyl group, which may carry up to 3 substituents selected from halogen atoms, optionally substituted phenyl groups, and (C1-C3)-alkoxy, -alkylthio and -alkylsulphonyl groups or R4 represents a (C3-C8)cycloalkyl group, a cyano, hydroxy, nitro or optionally substituted phenoxy group, or a group , -COR5 (wherein R5 represents a (C1-C4)-alkyl or -alkoxy group, a hydroxy group, or an optionally substituted phenyl group) or a (C1-C6)alkanoylamino group, or R4 represents a group -S(O)nR6, -SO2NR7R8 or -CZ2NR7R8 (wherein n represents 0; 1 or 2, R6 represents a (C1-C4)alkyl or (C2-C4)alkenyl group, which may carry an optionally substituted phenyl substituent, a (C3-C8)cyclo-alkyl group or an optionally substituted phenyl group, R7 and R8 each represents hydrogen or a (C1-C4)alkyl or (C2-C4)alkenyl group, which may carry an optionally substituted phenyl substituent, or a (C3-C8)cycloalkyl group or an optionally substituted phenyl group, or the group -NR7R8 represents a heterocyclic group, and Z2 represents an oxygen or sulphur atom), A2 represents a nitrogen atom or, when A1 represents a nitrogen atom, A2 represents a nitrogen atom or a group -CR3= wherein R3 is as hereinbefore defined, Z1 represents an oxygen or sulphur atom, and R2 represents a group of the formula -S(O)nR6, -SO2NR7R8, -CSNR7R8, -CONR7R9 or -CZ2NHNO2, wherein n, R6, R7, R8 and Z2 are as hereinbefore defined, and the group -NR7R9 represents a heterocyclic group, or R7 is as hereinbefore defined and R9 represents a (C1-C4)alkyl or (C2-C4)alkenyl group which carries an optionally substituted phenyl substituent, or an optionally substituted phenyl group or, when A1 represents a nitrogen atom or a group -CR4= wherein R4 is as hereinbefore defined and Z1 and A2 are as hereinbefore defined or, when Al represents a group -CH= and Z1 represents a sulphur atom and A2 is as hereinbefore defined, R2 represents a group of the formula -S(O)nR6, -SO2NR7R8, -CZ2NR7R8 or CZ2NHNO2 wherein n, R6, R7, R8 and Z2 are as hereinbefore defined! are new therapeutically useful compounds possessing antineoplastic activity. Processes for the preparation of the tetrazine derivatives are inter alia described.
SE8304415A 1982-08-17 1983-08-15 TETRAZINE DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF SE455198B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8223583 1982-08-17
GB8223580 1982-08-17
GB8226169 1982-09-14
GB838306904A GB8306904D0 (en) 1983-03-14 1983-03-14 Compositions of matter

Publications (3)

Publication Number Publication Date
SE8304415D0 SE8304415D0 (en) 1983-08-15
SE8304415L true SE8304415L (en) 1984-02-18
SE455198B SE455198B (en) 1988-06-27

Family

ID=27449377

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304415A SE455198B (en) 1982-08-17 1983-08-15 TETRAZINE DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF

Country Status (18)

Country Link
AU (1) AU575782B2 (en)
BE (1) BE897548A (en)
CA (1) CA1254563A (en)
CH (1) CH657855A5 (en)
DE (1) DE3329505A1 (en)
DK (1) DK374983A (en)
ES (1) ES8502441A1 (en)
FI (1) FI80273C (en)
FR (1) FR2531958B1 (en)
GR (1) GR78688B (en)
HU (1) HU189321B (en)
IE (1) IE55849B1 (en)
IL (1) IL69500A (en)
IT (1) IT1194375B (en)
LU (1) LU84969A1 (en)
NL (1) NL8302863A (en)
NZ (1) NZ205272A (en)
SE (1) SE455198B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (en) * 1979-08-09 1981-02-26 Basf Ag Pyrrolo-, pyrazolo-, imidazo- and thiazolo-tetrazin-4-one derivs. - prepd. from amino-azole cpds. by diazotisation and reaction with isocyanate
OA07174A (en) * 1981-08-24 1984-04-30 May & Baker Ltd New imidazotetrazionones, their preparation and medicines containing them.

Also Published As

Publication number Publication date
IT8322566A0 (en) 1983-08-16
SE8304415D0 (en) 1983-08-15
FI80273C (en) 1990-05-10
CA1254563A (en) 1989-05-23
FR2531958B1 (en) 1986-10-31
DK374983D0 (en) 1983-08-16
FI832927A0 (en) 1983-08-15
FI832927A (en) 1984-02-18
FI80273B (en) 1990-01-31
IE831913L (en) 1984-02-17
AU575782B2 (en) 1988-08-11
DK374983A (en) 1984-02-18
IT1194375B (en) 1988-09-22
GR78688B (en) 1984-09-27
IE55849B1 (en) 1991-01-30
NZ205272A (en) 1986-12-05
ES524995A0 (en) 1985-01-01
CH657855A5 (en) 1986-09-30
NL8302863A (en) 1984-03-16
BE897548A (en) 1984-02-17
HU189321B (en) 1986-06-30
DE3329505A1 (en) 1984-02-23
LU84969A1 (en) 1984-03-23
FR2531958A1 (en) 1984-02-24
ES8502441A1 (en) 1985-01-01
SE455198B (en) 1988-06-27
IL69500A (en) 1989-01-31
AU1796883A (en) 1984-02-23

Similar Documents

Publication Publication Date Title
MY102084A (en) Cyclohexandionecarboxylic acid derivatives having a herbicidal and plant growth-regulating action.
KR850002015A (en) Method for preparing quinazoline derivatives
ES301102A1 (en) Procedure for the obtaining of new dihydrotean 3-2-dipyrimidines. (Machine-translation by Google Translate, not legally binding)
ES8406440A1 (en) Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity.
ES269967A1 (en) Pyrazolones and processes for their preparation
ES8102137A1 (en) 3-Vinyl-cephalosporins
GB1414213A (en) Urea derivatives processes for their preparation and compo sitions incorporating them
ES471239A1 (en) Thiazolidine compounds
SE8304415L (en) NEW TETRAZINE DERIVATIVES
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
ES8500935A1 (en) Pyridine derivatives.
DE3378467D1 (en) Process for preparing 5-perfluoroalkyl-5,6-dihydrouracil derivatives and compounds for use therein
ES8504771A1 (en) Pyridine derivatives.
ATE20588T1 (en) HETEROCYCLIC COMPOUNDS USABLE AS PESTICIDES AND PROCESS FOR THEIR PRODUCTION.
ES394907A1 (en) 1,2-dihydro-8-carbamoyloxyquinolines
ES447751A1 (en) Imidazolyl-2-quinazoline derivatives
ES417018A1 (en) Phosphorus derivatives of triazolin-5-ones and thiones
ES447219A1 (en) N-sulfonyl-N-dihalophenylimidazolidinediones
ES424500A1 (en) A procedure for the preparation of derivatives of 1-amino (replaced) -2-oxy) -2-propanol. (Machine-translation by Google Translate, not legally binding)
ES419660A1 (en) Isoquinolinium compounds
ES8105286A1 (en) Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing them.
ES8406065A1 (en) Trifluoromethanesulfonanilides, and their production and use.
KR840001584A (en) Process for preparing cephalosporin compound
GB1481158A (en) Derivatives of 1,2,4-oxadiazolidine-3-one and pesticidal compositions containing them
ES426329A1 (en) A procedure for the preparation of new derivatives of 1,2,3,4-tetrahidroisoquinoleina. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8304415-6

Effective date: 19910315

Format of ref document f/p: F